OTCMKTS:GNGBY

Getinge Q4 2025 Earnings Results & Report

Getinge logo
$26.88 -0.39 (-1.44%)
As of 11/20/2026 03:58 PM Eastern

Getinge reported Q4 2025 earnings on January 27, 2026. The company reported EPS of $0.47, while revenue was $1.08 billion.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Getinge EPS Results

Actual EPS
$0.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge Revenue Results

Actual Revenue
$1.08 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Getinge's next earnings date is estimated for Tuesday, January 26, 2027, based on past reporting schedules.

Conference Call Resources

Getinge Q4 2025 Earnings FAQ

Getinge (OTCMKTS:GNGBY) reported earnings of $0.47 per share for Q4 2025. The report was announced on Tuesday, January 27, 2026.

Getinge reported revenue of $1.08 billion for Q4 2025.

Getinge's next earnings date is estimated for Tuesday, January 26, 2027. MarketBeat tracks confirmed and estimated earnings dates for Getinge on the company's earnings history page.

Getinge Earnings Headlines

Getinge Establishes Sustainable Financing Framework
Seven bucks, yours for life: my Black Friday indicator deal
Base Camp Trading's Thomas Wood is giving away his proprietary Snapback Indicator for just $7 this Black Friday. Others paid $500 for it. It's a one-time price with no recurring billing, and the indicator is yours for life. It shows when it's time to sell or go short, and when it makes sense to buy. Check it for a potential Snapback before your next trade.tc pixel
Getinge AB Earnings Call Signals Steady Margin Climb
See More Getinge Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge and other key companies, straight to your email.

About Getinge

Getinge (OTCMKTS:GNGBY) is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products.

The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing.

Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.

View Getinge Profile